These findings are consistent with the notion that nab-paclitaxel facilitates the drug distribution by exploiting the physiological transporter properties of albumin and can explain why at commonly used clinical doses, nab-paclitaxel would deliver more active drugs to the tumor. Here, ALB is linked to neoplasm.